Medicine Henry Quentir Medicine Henry Quentir

PsiQuantum and AMD Expand Their Partnership on 12 November 2026 With Drug Discovery First: What the Covalent-Inhibitor Simulations and the PRISM Decoder Show

What PsiQuantum and AMD announced in Palo Alto and Santa Clara on 12 November 2026

Quentir Medicine Monitor

Evidence-based insights for quantum medicine.

PsiQuantum and AMD said on 12 November 2026 that their first commercial target for a joint quantum-classical computing platform is drug discovery, starting with chemistry that matters for cancer medicines. The two companies announced an expanded partnership to co-design the classical and photonic hardware that a fault-tolerant quantum computer will need, and AMD said it plans to take an equity stake in PsiQuantum.

The medical claim in the announcement is short. According to the joint press release published by PsiQuantum, PsiQuantum's computational chemistry workflows, run at large scale on AMD graphics processors, have "already delivered initial breakthrough results in simulation of covalent inhibitors, a class of molecules relevant in drug discovery for oncology." The release gives no molecule, no target protein, no accuracy figure and no publication. It also gives no amount for the planned AMD investment. For a pharmaceutical or hospital research reader, the useful work is to separate what was shown from what was announced.

Today's chemistry results come from conventional GPUs. The quantum machine they are meant to prepare for does not yet exist. PsiQuantum says its methods improve on current GPU-based approaches today while "preparing critical industries for the arrival of fault-tolerant quantum computing." Only the second of those claims depends on quantum hardware.

The partnership builds on an earlier choice: PsiQuantum had already selected AMD Versal FPGA chips, programmable processors that can be rewired in hardware, for the control electronics of its photonic quantum computer. The new agreement widens that relationship to AMD Instinct GPUs, AMD EPYC server processors and the AMD ROCm software stack, combined with PsiQuantum's silicon photonics platform. The companies describe the goal as a hybrid computing fabric in which classical supercomputing, AI and photonic quantum processors work together.

Read More